Continuous Manufacturing in the News
12 April 2016: With the launch of the FDA's recently-released draft guidance, Advancement of Emerging Technology Applications to Modernize the Pharmaceutical Manufacturing Base, continuous manufacturing is generating headlines as big pharmaceutical companies take on the task of transiting from batch processing to a more reliable continuous manufacturing model. Here from the FDA on how they're supporting this transition and how Janssen Products, a Johnson & Johnson company, received the first FDA approval to change their production method.
Attend these presentations at the ISPE Continuous Manufacturing Conference to hear from companies who are currently in operation and/or development phases of a continuous manufacturing model:
- Johnson & Johnson – Business Case Drivers and Deployment Strategies in the Current Landscape for Continuous Drug Product Manufacturing
10:30 - 11:00, Wednesday, 20 April
- Eli Lilly & Co. – Utilization of Online Chromatography Platforms in Drug Substance Continuous Processing: From Process Development to Manufacturing
11:30 - 12:00, Wednesday, 20 April
- Vertex – Continuous Manufacturing: Experiences Since Launch
17:15 - 17:45, Wednesday, 20 April
This conference is supported by the following ISPE Communities of Practice:
- Process Analytical Technology & Lifecycle Control Strategy
- Oral Solid Dosage
We are honored to have a speaker from one of the category winners of the 2016 Facility of the Year Awards (FOYA).